223 related articles for article (PubMed ID: 11342573)
1. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.
Imanishi Y; Hosokawa Y; Yoshimoto K; Schipani E; Mallya S; Papanikolaou A; Kifor O; Tokura T; Sablosky M; Ledgard F; Gronowicz G; Wang TC; Schmidt EV; Hall C; Brown EM; Bronson R; Arnold A
J Clin Invest; 2001 May; 107(9):1093-102. PubMed ID: 11342573
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 in parathyroid disease.
Mallya SM; Arnold A
Front Biosci; 2000 Mar; 5():D367-71. PubMed ID: 10704427
[TBL] [Abstract][Full Text] [Related]
4. CDK4/6 Dependence of Cyclin D1-Driven Parathyroid Neoplasia in Transgenic Mice.
Costa-Guda J; Corrado K; Bellizzi J; Romano R; Saria E; Saucier K; Rose M; Shah S; Alander C; Mallya S; Arnold A
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32877917
[TBL] [Abstract][Full Text] [Related]
5. Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism.
Mallya SM; Gallagher JJ; Wild YK; Kifor O; Costa-Guda J; Saucier K; Brown EM; Arnold A
Mol Endocrinol; 2005 Oct; 19(10):2603-9. PubMed ID: 15928311
[TBL] [Abstract][Full Text] [Related]
6. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
7. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
[TBL] [Abstract][Full Text] [Related]
8. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.
Hsi ED; Zukerberg LR; Yang WI; Arnold A
J Clin Endocrinol Metab; 1996 May; 81(5):1736-9. PubMed ID: 8626826
[TBL] [Abstract][Full Text] [Related]
10. [Cyclin D1 in sporadic parathyroid adenomas].
Imanishi Y
Clin Calcium; 2001 Dec; 11(12):1637-41. PubMed ID: 15775480
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of hyperparathyroidism and potential targets for drug development.
Krebs LJ; Arnold A
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):167-79. PubMed ID: 12476790
[TBL] [Abstract][Full Text] [Related]
12. Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism.
Marx SJ
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S19-24; discussion S31-2. PubMed ID: 1684885
[TBL] [Abstract][Full Text] [Related]
13. [Primary hyperparathyroidism].
Hertig A; Maruani G; Paillard M; Houillier P
Nephrologie; 2000; 21(6):283-90. PubMed ID: 11117107
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma.
Mallya SM; Wu HI; Saria EA; Corrado KR; Arnold A
J Bone Miner Res; 2010 Dec; 25(12):2606-12. PubMed ID: 20641034
[TBL] [Abstract][Full Text] [Related]
15. Cycling with the parathyroid.
Silver J
J Clin Invest; 2001 May; 107(9):1079-80. PubMed ID: 11342570
[No Abstract] [Full Text] [Related]
16. Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure.
Brown EM; Wilson RE; Eastman RC; Pallotta J; Marynick SP
J Clin Endocrinol Metab; 1982 Jan; 54(1):172-9. PubMed ID: 7054214
[TBL] [Abstract][Full Text] [Related]
17. Update on genetic and clinical aspects of primary hyperparathyroidism.
Miedlich S; Krohn K; Paschke R
Clin Endocrinol (Oxf); 2003 Nov; 59(5):539-54. PubMed ID: 14616876
[TBL] [Abstract][Full Text] [Related]
18. Circadian rhythms for calcium, inorganic phosphorus, and parathyroid hormone in primary hyperparathyroidism: functional and practical considerations.
Lobaugh B; Neelon FA; Oyama H; Buckley N; Smith S; Christy M; Leight GS
Surgery; 1989 Dec; 106(6):1009-16; discussion 1016-7. PubMed ID: 2588106
[TBL] [Abstract][Full Text] [Related]
19. Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism.
Chudek J; Nagy A; Kokot F; Podwinski A; Wiecek A; Ritz E; Kovacs G
J Nephrol; 2007; 20(2):164-72. PubMed ID: 17514620
[TBL] [Abstract][Full Text] [Related]
20. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
